COVID-19 Impact on Fenofibrate Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Fenofibrate Industry
1.7 COVID-19 Impact: Fenofibrate Market Trends
2 Global Fenofibrate Quarterly Market Size Analysis
2.1 Fenofibrate Business Impact Assessment - COVID-19
2.1.1 Global Fenofibrate Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Fenofibrate Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Fenofibrate Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Fenofibrate Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Fenofibrate Factory Price by Manufacturers
3.3 Location of Key Manufacturers Fenofibrate Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Fenofibrate Market
3.5 Key Manufacturers Fenofibrate Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Fenofibrate Segments, By Type
4.1 Introduction
1.4.1 Tablet
1.4.2 Capsule
4.2 By Type, Global Fenofibrate Market Size, 2019-2021
4.2.1 By Type, Global Fenofibrate Market Size by Type, 2020-2021
4.2.2 By Type, Global Fenofibrate Price, 2020-2021
5 Impact of Covid-19 on Fenofibrate Segments, By Application
5.1 Overview
5.5.1 Hospital
5.5.2 Drug store
5.2 By Application, Global Fenofibrate Market Size, 2019-2021
5.2.1 By Application, Global Fenofibrate Market Size by Application, 2019-2021
5.2.2 By Application, Global Fenofibrate Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Business Overview
7.1.2 AbbVie Fenofibrate Quarterly Production and Revenue, 2020
7.1.3 AbbVie Fenofibrate Product Introduction
7.1.4 AbbVie Response to COVID-19 and Related Developments
7.2 Lupin
7.2.1 Lupin Business Overview
7.2.2 Lupin Fenofibrate Quarterly Production and Revenue, 2020
7.2.3 Lupin Fenofibrate Product Introduction
7.2.4 Lupin Response to COVID-19 and Related Developments
7.3 Salix Pharmaceuticals
7.3.1 Salix Pharmaceuticals Business Overview
7.3.2 Salix Pharmaceuticals Fenofibrate Quarterly Production and Revenue, 2020
7.3.3 Salix Pharmaceuticals Fenofibrate Product Introduction
7.3.4 Salix Pharmaceuticals Response to COVID-19 and Related Developments
7.4 Vectura
7.4.1 Vectura Business Overview
7.4.2 Vectura Fenofibrate Quarterly Production and Revenue, 2020
7.4.3 Vectura Fenofibrate Product Introduction
7.4.4 Vectura Response to COVID-19 and Related Developments
7.5 Cipher Pharmaceuticals
7.5.1 Cipher Pharmaceuticals Business Overview
7.5.2 Cipher Pharmaceuticals Fenofibrate Quarterly Production and Revenue, 2020
7.5.3 Cipher Pharmaceuticals Fenofibrate Product Introduction
7.5.4 Cipher Pharmaceuticals Response to COVID-19 and Related Developments
7.6 Rhodes Pharmaceuticals
7.6.1 Rhodes Pharmaceuticals Business Overview
7.6.2 Rhodes Pharmaceuticals Fenofibrate Quarterly Production and Revenue, 2020
7.6.3 Rhodes Pharmaceuticals Fenofibrate Product Introduction
7.6.4 Rhodes Pharmaceuticals Response to COVID-19 and Related Developments
7.7 Impax Laboratories
7.7.1 Impax Laboratories Business Overview
7.7.2 Impax Laboratories Fenofibrate Quarterly Production and Revenue, 2020
7.7.3 Impax Laboratories Fenofibrate Product Introduction
7.7.4 Impax Laboratories Response to COVID-19 and Related Developments
7.8 Mylan
7.8.1 Mylan Business Overview
7.8.2 Mylan Fenofibrate Quarterly Production and Revenue, 2020
7.8.3 Mylan Fenofibrate Product Introduction
7.8.4 Mylan Response to COVID-19 and Related Developments
7.9 Teva
7.9.1 Teva Business Overview
7.9.2 Teva Fenofibrate Quarterly Production and Revenue, 2020
7.9.3 Teva Fenofibrate Product Introduction
7.9.4 Teva Response to COVID-19 and Related Developments
7.10 Sun Pharmaceutical
7.10.1 Sun Pharmaceutical Business Overview
7.10.2 Sun Pharmaceutical Fenofibrate Quarterly Production and Revenue, 2020
7.10.3 Sun Pharmaceutical Fenofibrate Product Introduction
7.10.4 Sun Pharmaceutical Response to COVID-19 and Related Developments
7.11 Bausch Health
7.11.1 Bausch Health Business Overview
7.11.2 Bausch Health Fenofibrate Quarterly Production and Revenue, 2020
7.11.3 Bausch Health Fenofibrate Product Introduction
7.11.4 Bausch Health Response to COVID-19 and Related Developments
7.12 HETERO
7.12.1 HETERO Business Overview
7.12.2 HETERO Fenofibrate Quarterly Production and Revenue, 2020
7.12.3 HETERO Fenofibrate Product Introduction
7.12.4 HETERO Response to COVID-19 and Related Developments
7.13 Aurobindo Pharma
7.13.1 Aurobindo Pharma Business Overview
7.13.2 Aurobindo Pharma Fenofibrate Quarterly Production and Revenue, 2020
7.13.3 Aurobindo Pharma Fenofibrate Product Introduction
7.13.4 Aurobindo Pharma Response to COVID-19 and Related Developments
7.14 Cipla
7.14.1 Cipla Business Overview
7.14.2 Cipla Fenofibrate Quarterly Production and Revenue, 2020
7.14.3 Cipla Fenofibrate Product Introduction
7.14.4 Cipla Response to COVID-19 and Related Developments
7.15 Amneal Pharmaceuticals
7.15.1 Amneal Pharmaceuticals Business Overview
7.15.2 Amneal Pharmaceuticals Fenofibrate Quarterly Production and Revenue, 2020
7.15.3 Amneal Pharmaceuticals Fenofibrate Product Introduction
7.15.4 Amneal Pharmaceuticals Response to COVID-19 and Related Developments
7.16 Prinston Pharmaceutical
7.16.1 Prinston Pharmaceutical Business Overview
7.16.2 Prinston Pharmaceutical Fenofibrate Quarterly Production and Revenue, 2020
7.16.3 Prinston Pharmaceutical Fenofibrate Product Introduction
7.16.4 Prinston Pharmaceutical Response to COVID-19 and Related Developments
7.17 Dr. Reddys Laboratories
7.17.1 Dr. Reddys Laboratories Business Overview
7.17.2 Dr. Reddys Laboratories Fenofibrate Quarterly Production and Revenue, 2020
7.17.3 Dr. Reddys Laboratories Fenofibrate Product Introduction
7.17.4 Dr. Reddys Laboratories Response to COVID-19 and Related Developments
7.18 APOTEX
7.18.1 APOTEX Business Overview
7.18.2 APOTEX Fenofibrate Quarterly Production and Revenue, 2020
7.18.3 APOTEX Fenofibrate Product Introduction
7.18.4 APOTEX Response to COVID-19 and Related Developments
7.19 Glenmark
7.19.1 Glenmark Business Overview
7.19.2 Glenmark Fenofibrate Quarterly Production and Revenue, 2020
7.19.3 Glenmark Fenofibrate Product Introduction
7.19.4 Glenmark Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Fenofibrate Supply Chain Analysis
8.1.1 Fenofibrate Supply Chain Analysis
8.1.2 Covid-19 Impact on Fenofibrate Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Fenofibrate Distribution Channels
8.2.2 Covid-19 Impact on Fenofibrate Distribution Channels
8.2.3 Fenofibrate Distributors
8.3 Fenofibrate Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Fenofibrate Assessment
Table 9. COVID-19 Impact: Fenofibrate Market Trends
Table 10. COVID-19 Impact Global Fenofibrate Market Size
Table 11. Global Fenofibrate Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Fenofibrate Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Fenofibrate Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Fenofibrate Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Fenofibrate Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Fenofibrate Market Growth Drivers
Table 17. Global Fenofibrate Market Restraints
Table 18. Global Fenofibrate Market Opportunities
Table 19. Global Fenofibrate Market Challenges
Table 20. Key Manufacturers Fenofibrate Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Fenofibrate Market Size, 2019 (K MT) & (US$ Million)
Table 22. Fenofibrate Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Fenofibrate Manufacturing Plants
Table 24. Key Manufacturers Fenofibrate Market Served
Table 25. Date of Key Manufacturers Enter into Fenofibrate Market
Table 26. Key Manufacturers Fenofibrate Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Fenofibrate Market Size by Type, 2020, (US$ Million)
Table 29. Global Fenofibrate Market Size by Type, 2020 (K MT)
Table 30. Global Fenofibrate Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Fenofibrate Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Fenofibrate Market Size by Application, 2020-2021 (K MT)
Table 33. Global Fenofibrate Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Fenofibrate Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Fenofibrate Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Fenofibrate Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Fenofibrate Market Size, 2019-2021 (K MT)
Table 38. US Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Fenofibrate Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Fenofibrate Market Size, 2019-2021 (K MT)
Table 43. Germany Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Fenofibrate Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Fenofibrate Market Size, 2019-2021 (K MT)
Table 50. China Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Fenofibrate Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. AbbVie Business Overview
Table 58. AbbVie Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. AbbVie Fenofibrate Product
Table 60. AbbVie Response to COVID-19 and Related Developments
Table 61. Lupin Business Overview
Table 62. Lupin Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Lupin Fenofibrate Product
Table 64. Lupin Response to COVID-19 and Related Developments
Table 65. Salix Pharmaceuticals Business Overview
Table 66. Salix Pharmaceuticals Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Salix Pharmaceuticals Fenofibrate Product
Table 68. Salix Pharmaceuticals Response to COVID-19 and Related Developments
Table 69. Vectura Business Overview
Table 70. Vectura Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Vectura Fenofibrate Product
Table 72. Vectura Response to COVID-19 and Related Developments
Table 73. Cipher Pharmaceuticals Business Overview
Table 74. Cipher Pharmaceuticals Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Cipher Pharmaceuticals Fenofibrate Product
Table 76. Cipher Pharmaceuticals Response to COVID-19 and Related Developments
Table 77. Rhodes Pharmaceuticals Business Overview
Table 78. Rhodes Pharmaceuticals Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Rhodes Pharmaceuticals Fenofibrate Product
Table 80. Rhodes Pharmaceuticals Response to COVID-19 and Related Developments
Table 81. Impax Laboratories Business Overview
Table 82. Impax Laboratories Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Impax Laboratories Fenofibrate Product
Table 84. Impax Laboratories Response to COVID-19 and Related Developments
Table 85. Mylan Business Overview
Table 86. Mylan Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Mylan Fenofibrate Product
Table 88. Mylan Response to COVID-19 and Related Developments
Table 89. Teva Business Overview
Table 90. Teva Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Teva Fenofibrate Product
Table 92. Teva Response to COVID-19 and Related Developments
Table 93. Sun Pharmaceutical Business Overview
Table 94. Sun Pharmaceutical Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sun Pharmaceutical Fenofibrate Product
Table 96. Sun Pharmaceutical Response to COVID-19 and Related Developments
Table 97. Bausch Health Business Overview
Table 98. Bausch Health Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Bausch Health Fenofibrate Product
Table 100. Bausch Health Response to COVID-19 and Related Developments
Table 101. HETERO Business Overview
Table 102. HETERO Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. HETERO Fenofibrate Product
Table 104. HETERO Response to COVID-19 and Related Developments
Table 105. Aurobindo Pharma Business Overview
Table 106. Aurobindo Pharma Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Aurobindo Pharma Fenofibrate Product
Table 108. Aurobindo Pharma Response to COVID-19 and Related Developments
Table 109. Cipla Business Overview
Table 110. Cipla Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Cipla Fenofibrate Product
Table 112. Cipla Response to COVID-19 and Related Developments
Table 113. Amneal Pharmaceuticals Business Overview
Table 114. Amneal Pharmaceuticals Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Amneal Pharmaceuticals Fenofibrate Product
Table 116. Amneal Pharmaceuticals Response to COVID-19 and Related Developments
Table 117. Prinston Pharmaceutical Business Overview
Table 118. Prinston Pharmaceutical Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Prinston Pharmaceutical Fenofibrate Product
Table 120. Prinston Pharmaceutical Response to COVID-19 and Related Developments
Table 121. Dr. Reddys Laboratories Business Overview
Table 122. Dr. Reddys Laboratories Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Dr. Reddys Laboratories Fenofibrate Product
Table 124. Dr. Reddys Laboratories Response to COVID-19 and Related Developments
Table 125. APOTEX Business Overview
Table 126. APOTEX Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. APOTEX Fenofibrate Product
Table 128. APOTEX Response to COVID-19 and Related Developments
Table 129. Glenmark Business Overview
Table 130. Glenmark Fenofibrate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Glenmark Fenofibrate Product
Table 132. Glenmark Response to COVID-19 and Related Developments
Table 133. Fenofibrate Distributors List
Table 134. Fenofibrate Customers List
Table 135. Covid-19 Impact on Fenofibrate Customers
List of FiguresFigure 1. Fenofibrate Product Picture
Figure 2. Fenofibrate Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Fenofibrate Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Fenofibrate Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Fenofibrate Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Fenofibrate Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Fenofibrate Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Fenofibrate Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Fenofibrate Market Size Market Share, 2019-2021